MARSHALL WACE, LLP - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of QIAGEN NV
ValueSharesWeighting
Q4 2016$2,695,000
-70.1%
96,165
-70.7%
0.02%
-71.9%
Q3 2016$9,013,000
+130.2%
328,456
+83.0%
0.06%
+93.9%
Q2 2016$3,915,000
+185.8%
179,515
+192.8%
0.03%
+153.8%
Q1 2016$1,370,000
+450.2%
61,307
+581.2%
0.01%
+550.0%
Q4 2015$249,000
-90.0%
9,000
-91.0%
0.00%
-93.8%
Q2 2015$2,482,000100,1370.03%
Other shareholders
QIAGEN NV shareholders Q4 2016
NameSharesValueWeighting ↓
Hardman Johnston Global Advisors LLC 6,178,402$170,833,00011.32%
Tikvah Management LLC 369,425$10,215,0005.35%
BLUE JAY CAPITAL MANAGEMENT, LLC 360,000$9,954,0003.36%
Opus Point Partners Management, LLC 160,000$4,424,0002.92%
Exane Asset Management 106,238$2,910,304,0001.76%
Douglas C. Lane & Associates, Inc. 1,918,338$53,042,0001.44%
Granahan Investment Management 1,051,000$29,060,0001.00%
CRAMER ROSENTHAL MCGLYNN LLC 2,285,569$63,196,0000.95%
Sivik Global Healthcare LLC 70,000$1,936,0000.92%
PURA VIDA INVESTMENTS, LLC 78,668$2,175,0000.92%
View complete list of QIAGEN NV shareholders